LOS ANGELES and LONDON, February 4, 2025 – Marlin Equity Partners (“Marlin”) is pleased to announce that it has acquired EIDO Healthcare (“EIDO”), a provider of digital consent and patient information solutions. EIDO will be merged with Radar Healthcare, an existing Marlin portfolio company and a provider of risk, quality, and compliance software for the healthcare and social care sectors, further strengthening Radar Healthcare’s position in the market and enhancing its ability to deliver high-quality tools for organizations across the health and care landscape, supporting safer and more effective care.
“This is an exciting new chapter for Radar Healthcare,” said Paul Johnson, CEO of Radar Healthcare. “We are thrilled to have EIDO joining us to grow our ecosystem and enhance what we can offer to healthcare and care providers. Both organizations share a deep passion for improving healthcare, and together, we can address new challenges while continuing to deliver exceptional service and innovation to our customers.”
“At EIDO, we are proud of our long-standing reputation for providing trusted patient information solutions,” said Matthew Ravenscroft, CEO of EIDO. “This strategic investment from Radar Healthcare allows us to build on this legacy, combining our strengths to better support healthcare providers and empower patients with clear, reliable information. This will allow us to enhance digital consent processes through our suite of resources designed to support healthcare professionals and reduce the risk of litigation as well as enhance the patient experience. We look forward to embarking on this transformative journey together.”
“We are excited to work alongside EIDO following the strategic investment from Radar Healthcare,” said Chris Clasper, a principal at Marlin. “Both organizations have a proven commitment to excellence and are united in their passion to offer their customers the best possible digital solutions to achieve their goals.”
About Marlin Equity Partners
Marlin Equity Partners is a global investment firm with over $9 billion in capital commitments. The firm is focused on providing corporate parents, shareholders and other stakeholders with tailored solutions that meet their business and liquidity needs. Marlin invests in businesses across multiple industries where its capital base, industry relationships and extensive network of operational resources significantly strengthen a company’s outlook and enhance value. Since its inception, Marlin, through its group of funds and related companies, has successfully completed over 250 acquisitions. The firm is headquartered in Los Angeles, California, with an additional office in London. For more information, please visit www.marlinequity.com.
About Radar Healthcare
Radar Healthcare empowers health and social care organizations to make a meaningful impact on patient safety and quality of care. By blending digital innovation with real-world healthcare expertise, Radar Healthcare enables providers to not only meet regulatory standards but to actively spot trends, prevent incidents, and drive continuous improvement. Designed with flexibility and adaptability in mind, and with a deep understanding of the daily challenges in health and care, Radar Healthcare is dedicated to evolving alongside the industry, delivering a system that is valued for its role in shaping safer, more effective care. For more information, please visit www.radarhealthcare.com.
Contacts:
Peter Spasov
(310) 364-0100
pspasov@marlinequity.com